Targeting HER 2 and angiogenesis in gastric cancer.

about

Intracranial hypertension as the primary symptom of gastric signet-ring cell carcinoma: A case report and literature review.Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.

P2860

Q37226316-6183B807-D2C9-483C-9604-98C8909A2E6C Q51026487-5151CF63-BA33-453D-8F2E-CA69201ECE36

P2860

Targeting HER 2 and angiogenesis in gastric cancer.

Item

http://www.wikidata.org/entity/Q38633308

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Targeting HER 2 and angiogenesis in gastric cancer.

@en

type

Item

label

Targeting HER 2 and angiogenesis in gastric cancer.

@en

prefLabel

Targeting HER 2 and angiogenesis in gastric cancer.

@en

P1476

Targeting HER 2 and angiogenesis in gastric cancer.

@en

P2093

G Jomrich

http://www.w3.org/2001/XMLSchema#string

S F Schoppmann

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells

Humanization of an anti-p185HER2 antibody for human cancer therapy

Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value

Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.

Global cancer statistics, 2002

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

P304

111-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2016.1121110

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sebastian F Schoppmann

G Jomrich

P577

2015-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26567753

http://www.w3.org/2001/XMLSchema#string

Targeting HER 2 and angiogenesis in gastric cancer.

about

P2860

P2860

Targeting HER 2 and angiogenesis in gastric cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698